Display options
Cite
Mitchell R. Hematopoietic Stem Cell Transplantation Beyond Severe Combined Immunodeficiency: Seeking a Cure for Primary Immunodeficiency. J Allergy Clin Immunol Pract. 2019;7(3):776-785doi: 10.1016/j.jaip.2018.12.011.
Mitchell, R. (2019). Hematopoietic Stem Cell Transplantation Beyond Severe Combined Immunodeficiency: Seeking a Cure for Primary Immunodeficiency. The journal of allergy and clinical immunology. In practice, 7(3), 776-785. https://doi.org/10.1016/j.jaip.2018.12.011
Mitchell, Richard. "Hematopoietic Stem Cell Transplantation Beyond Severe Combined Immunodeficiency: Seeking a Cure for Primary Immunodeficiency." The journal of allergy and clinical immunology. In practice vol. 7,3 (2019): 776-785. doi: https://doi.org/10.1016/j.jaip.2018.12.011
Mitchell R. Hematopoietic Stem Cell Transplantation Beyond Severe Combined Immunodeficiency: Seeking a Cure for Primary Immunodeficiency. J Allergy Clin Immunol Pract. 2019 Mar;7(3):776-785. doi: 10.1016/j.jaip.2018.12.011. PMID: 30832892.
Copy Download .nbib Format: NLM
Share it on

J Allergy Clin Immunol Pract. 2019 Mar;7(3):776-785. doi: 10.1016/j.jaip.2018.12.011.

Hematopoietic Stem Cell Transplantation Beyond Severe Combined Immunodeficiency: Seeking a Cure for Primary Immunodeficiency.

The journal of allergy and clinical immunology. In practice

Richard Mitchell

Affiliations

  1. Kids Cancer Centre, Sydney Children's Hospital, Randwick, New South Wales, Australia; School of Women and Children's Health, University of New South Wales, Sydney, New South Wales, Australia. Electronic address: [email protected].

PMID: 30832892 DOI: 10.1016/j.jaip.2018.12.011

Abstract

Hematopoietic stem cell transplantation (HSCT) can provide definitive therapy for patients with primary immunodeficiency disease (PIDD). Modern HSCT techniques and supportive care have significantly improved outcomes for patients with PIDD. This review examines current HSCT practice for PIDD other than severe combined immunodeficiency, and explores indications, risks, and long-term outcomes for this group of challenging diseases.

Crown Copyright © 2018. Published by Elsevier Inc. All rights reserved.

Keywords: Hematopoietic stem cell transplantation; Primary immunodeficiency; Reduced intensity conditioning

MeSH terms

Publication Types